Although the vast majority of patients with a large-bowel primary have tumors amenable to curative resection at the time of diagnosis, the disease recurs in more than half of the patients, with the liver involved in up to two-thirds of the cases. Synchronous liver metastases are diagnosed in approximately 15% of the cases. In such patients, liver disease represents the sole site of distant metastases in more than 75%. Metachronous liver metastases develop in 16–20% of patients usually within the first 3 years. Untreated liver metastases have a grim prognosis. Liver resection is the only potentially curative treatment although only 20% of patients can be considered as candidates for surgery.
Colorectal Cancer Rectal Cancer Liver Metastasis Hepatic Resection Hepatic Metastasis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefGoogle Scholar
Center MM, Jemal A, Smith RA et al (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378CrossRefGoogle Scholar
Italian cancer trends (1998–2005). Report 2009. Available at http://www.registritumori. it/PDF/AIRTUM2009Trend/E&P33_4-5S1_38_colonretto.pdf. Accessed May, 15th, 2010Google Scholar
Manfredi S, Lepage C, Hatem C et al (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244:254–259CrossRefGoogle Scholar
Manfredi S, Bouvier AM, Lepage C et al (2006) Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 93:1115–1122CrossRefGoogle Scholar
Leporrier J, Maurel J, Chiche L et al (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474CrossRefGoogle Scholar
Gatta G, Capocaccia R, Sant M et al (2000) Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 47:533–538CrossRefGoogle Scholar
Phelip JM, Grosclaude P, Launoy G (2005) Are there regional differences in the management of colon cancer in France? Eur J Cancer 131:504–510Google Scholar
Kune GA, Kune S, Field B et al (1990) Survival in patients with large-bowel cancer: a population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 33:938–946CrossRefGoogle Scholar
Bengtsson G, Carlsson G, Hafstrom L et al (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141:586–589CrossRefGoogle Scholar
Norstein J, Silen W (1997) Natural history of liver metastases from colo-rectal carcinoma. J Gastrointest Surg 1:398–407CrossRefGoogle Scholar
Stangl R, Altendorf-Hofmann A, Charnley RM et al (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405–1410CrossRefGoogle Scholar
Wagner JS, Adson MA, Adson MH et al (1984) The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199:502–507CrossRefGoogle Scholar
Wood CB, Gillis CR, Blumgart LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285–288PubMedGoogle Scholar
Rougier P, Milan C, Lazorthes F et al (1995) Prospective study of prognostic factors in patients with unresected metastases from colorectal cancer. Br J Surg 82:1397–1400CrossRefGoogle Scholar
Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677–3683CrossRefGoogle Scholar